Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SPP1 improves early risk assessment of postpartum adverse events in pulmonary arterial hypertension complicated with pregnancy.

European journal of obstetrics, gynecology, and reproductive biology·2026
Same author

Altered early-life gut microbiota in offspring of pregnancies complicated by CHD-associated pulmonary hypertension.

Frontiers in microbiomes·2026
Same author

Regulating Electrostatic Discharge via Quasi-gate Electrode for High-Performance Direct-current Triboelectric Nanogenerators.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Synergistic Effects of Normal-Range Serum Sodium and Potassium on Mortality: The Modifying Role of Inflammation From a NHANES Cohort Analysis.

Chronic diseases and translational medicine·2026
Same author

Transcriptomics and Mendelian randomization studies reveal the critical role of Stanniocalcin-2 in linking perfluorinated compound-exposure to colorectal cancer.

Frontiers in public health·2026
Same author

Environmental Noise and Cardiovascular Risk: A Causal Inference Study.

Noise & health·2026

Related Experiment Video

Updated: Oct 7, 2025

Candida albicans Biofilm Chip CaBChip for High-throughput Antifungal Drug Screening
08:05

Candida albicans Biofilm Chip CaBChip for High-throughput Antifungal Drug Screening

Published on: July 18, 2012

13.8K

Recent Developments on Using Nanomaterials to Combat Candida albicans.

Bingxin Li1, Luyao Pan1, Haofeng Zhang1

  • 1Department of Gynecology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

Frontiers in Chemistry
|January 10, 2022
PubMed
Summary

Nanomaterials show promise in combating drug-resistant Candida albicans infections causing vaginal candidiasis. These advanced materials improve antifungal drug delivery and efficacy against biofilms.

Keywords:
Candida albicansantifungal applicationsbiofilmsnanomaterialsvaginal candidiasis

More Related Videos

Daily Phototherapy with Red Light to Regulate Candida albicans Biofilm Growth
11:06

Daily Phototherapy with Red Light to Regulate Candida albicans Biofilm Growth

Published on: April 23, 2019

7.9K
A 96 Well Microtiter Plate-based Method for Monitoring Formation and Antifungal Susceptibility Testing of Candida albicans Biofilms
07:19

A 96 Well Microtiter Plate-based Method for Monitoring Formation and Antifungal Susceptibility Testing of Candida albicans Biofilms

Published on: October 21, 2010

45.4K

Related Experiment Videos

Last Updated: Oct 7, 2025

Candida albicans Biofilm Chip CaBChip for High-throughput Antifungal Drug Screening
08:05

Candida albicans Biofilm Chip CaBChip for High-throughput Antifungal Drug Screening

Published on: July 18, 2012

13.8K
Daily Phototherapy with Red Light to Regulate Candida albicans Biofilm Growth
11:06

Daily Phototherapy with Red Light to Regulate Candida albicans Biofilm Growth

Published on: April 23, 2019

7.9K
A 96 Well Microtiter Plate-based Method for Monitoring Formation and Antifungal Susceptibility Testing of Candida albicans Biofilms
07:19

A 96 Well Microtiter Plate-based Method for Monitoring Formation and Antifungal Susceptibility Testing of Candida albicans Biofilms

Published on: October 21, 2010

45.4K

Area of Science:

  • Mycology
  • Nanotechnology
  • Infectious Diseases

Background:

  • Vaginal candidiasis (VC), primarily caused by Candida albicans, is a prevalent women's health issue.
  • Increasing drug resistance and Candida albicans biofilms pose significant global health challenges.
  • Traditional antifungal drugs suffer from low bioavailability, limiting treatment effectiveness.

Purpose of the Study:

  • To review recent advancements in using nanomaterials to combat Candida albicans infections.
  • To highlight the potential of various nanomaterials in overcoming antifungal drug resistance and improving bioavailability.

Main Methods:

  • Review of current literature on nanomaterial applications in antifungal therapy.
  • Focus on inorganic nanoparticles (e.g., silver nanoparticles) and nanocarrier systems (liposomes, polymeric nanoparticles, MOFs, COFs).

Main Results:

  • Nanomaterials, including silver nanoparticles, demonstrate inherent antifungal properties.
  • Nanocarrier systems effectively enhance the bioavailability of antifungal agents.
  • Various nanomaterials show potential in overcoming Candida albicans drug resistance and biofilm formation.

Conclusions:

  • Nanomaterials offer a promising strategy to address the challenges of drug-resistant vaginal candidiasis.
  • Further research into nanomaterial-based antifungal therapies is warranted to improve treatment outcomes.